Date published: 2025-12-18

1-800-457-3801

SCBT Portrait Logo
Seach Input

EVI2B Inhibitors

EVI2B inhibitors refer to a class of chemical compounds that are specifically designed to target and modulate the activity of the EVI2B protein. EVI2B, or Ecotropic Viral Integration Site 2B, is a transmembrane protein associated with various cellular processes, including signal transduction, membrane dynamics, and protein trafficking. While the primary function of EVI2B remains a subject of ongoing research, it is often implicated in regulating key cellular pathways, making it an attractive target for scientific investigation.

These inhibitors are meticulously designed to interfere with EVI2B's function by either directly binding to the protein or disrupting its associated signaling pathways. The mechanisms of action can vary widely among EVI2B inhibitors, but their overarching goal is to modulate the cellular responses and functions influenced by EVI2B. Researchers have developed a diverse range of small molecules that belong to the EVI2B inhibitor class, each with distinct chemical structures and modes of action. These inhibitors have become valuable tools in deciphering the precise roles of EVI2B in cellular processes and understanding its contributions to diseases. As the scientific community continues to investigate the functions and interactions of EVI2B, the development and refinement of EVI2B inhibitors are likely to play a crucial role in advancing our knowledge of this enigmatic protein and its implications for various biological contexts.

SEE ALSO...

Items 1 to 10 of 11 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Selumetinib

606143-52-6sc-364613
sc-364613A
sc-364613B
sc-364613C
sc-364613D
5 mg
10 mg
100 mg
500 mg
1 g
$28.00
$80.00
$412.00
$1860.00
$2962.00
5
(1)

Inhibits MEK1/2, downstream of Evi2B, in the MAPK pathway.

Sorafenib

284461-73-0sc-220125
sc-220125A
sc-220125B
5 mg
50 mg
500 mg
$56.00
$260.00
$416.00
129
(3)

Targets RAF kinases and inhibits downstream signaling.

Erlotinib Hydrochloride

183319-69-9sc-202154
sc-202154A
10 mg
25 mg
$74.00
$119.00
33
(1)

Blocks EGFR signaling, a pathway connected to Evi2B.

Vandetanib

443913-73-3sc-220364
sc-220364A
5 mg
50 mg
$167.00
$1353.00
(1)

Targets VEGFR, EGFR, and RET, impacting Evi2B signaling.

Lapatinib

231277-92-2sc-353658
100 mg
$412.00
32
(1)

Dual inhibitor of EGFR and HER2, part of Evi2B-related cascades.

Dasatinib

302962-49-8sc-358114
sc-358114A
25 mg
1 g
$47.00
$145.00
51
(1)

Tyrosine kinase inhibitor, modulating Evi2B-associated pathways.

Regorafenib

755037-03-7sc-477163
sc-477163A
25 mg
50 mg
$320.00
$430.00
3
(0)

Targets multiple kinases, including those linked to Evi2B.

Imatinib

152459-95-5sc-267106
sc-267106A
sc-267106B
10 mg
100 mg
1 g
$25.00
$117.00
$209.00
27
(1)

Inhibits BCR-ABL and c-KIT kinases, affecting Evi2B pathways.

Pazopanib Hydrochloride

635702-64-6sc-364564
sc-364564A
10 mg
25 mg
$107.00
$230.00
1
(1)

Targets VEGFR, PDGFR, and c-Kit, impacting Evi2B signaling.

Nilotinib

641571-10-0sc-202245
sc-202245A
10 mg
25 mg
$205.00
$405.00
9
(1)

Inhibits BCR-ABL kinase, affecting Evi2B-related cascades.